[P51] ポスターセッション 51　頭頸部（その他）

[P51-5] A phase 3 trial of xevinapant + concurrent chemoradiotherapy（CRT）for locally advanced head and neck cancer

^○田原 信¹, Cohen Ezra², Nutting Christopher³, Licitra Lisa^4,9, Burtness Barbara^5,10, Schoenfeld Jonathan⁶, Mokhtar Omar⁷, Bouisset Florilene⁷, Nauwelaerts Heidi⁷, Urfer Yulia⁷, Zanna Claudio⁷, Bourhis Jean⁸ (1.国立がん研究センター東病院 頭頸部内科, 2.University of California, 3.Royal Marsden NHS Foundation Trust, 4.Fondazione IRCCS Istituto Nazionale dei Tumori, 5.Yale School of Medicine, 6.Dana-Farber Cancer Institute, 7.Debiopharm International SA, 8.Centre Hospitalier Universitaire Vaudois, 9.University of Milan, 10.Yale Cancer Center)